Volume 12, Issue 2 ( June 2020 2020)                   Iranian Journal of Blood and Cancer 2020, 12(2): 64-66 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ramezani M, Heydari R, Amirian F, Sadeghi M. Papillary Adenocarcinoma of the Lung in a Young Man: A Case Report. Iranian Journal of Blood and Cancer 2020; 12 (2) :64-66
URL: http://ijbc.ir/article-1-938-en.html
1- Molecular Pathology Research Center, Imam Reza hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
2- Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
3- Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran , sadeghi_mbrc@yahoo.com
Abstract:   (2614 Views)
Lung cancer is the leading cause of cancer mortality worldwide. Adenocarcinoma is the most frequent pulmonary malignancy in most parts of the world. The papillary predominant subtype is applied when more than 75% of the tumor has the papillary architecture in histopathology. This subtype consists of about one-tenth of pulmonary adenocarcinomas. A 27-year-old man was referred with the history of dyspnea for the past three months. The patient had a diagnosis of right pulmonary empyema and was on medical treatment. After non-response he underwent surgery. The pathologist reported papillary adenocarcinoma of the lung, moderately differentiated with pleural involvement. Immunohistochemistry confirmed the diagnosis. Correct diagnosis of this subtype in histopathology is necessary for the determination of prognosis, cytogenetic changes, and selecting best treatment modalities.
Full-Text [PDF 2255 kb]   (1960 Downloads)    
: Case report | Subject: Pathology
Received: 2019/09/26 | Accepted: 2020/05/18 | Published: 2020/08/13

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Iranian Journal of Blood and Cancer

Designed & Developed by : Yektaweb